Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling
Jingyue Yao, Shu Xu, Yuening Sun, Ye Xu, Qinglong Guo, Libin Wei
Topics & Concepts
Cancer researchHepatocellular carcinomaMdm2KinaseApoptosisChemistryBiologyCell biologyBiochemistryCancer-related Molecular PathwaysSirtuins and Resveratrol in MedicineFlavonoids in Medical Research